- Home
- / BDI biotech
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
BDI biotech financials data including stock price, CreditSafe score, income statement, and balance sheet.
Total Funding
$4.7 M
Revenue
€2.6 M
Y, 2020
CreditSafe Score
?
Score changed on Jun 16, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | Y, 2019 | Y, 2020 |
|---|---|---|
| Revenue | 2.0M | 2.6M |
| Cost of goods sold | 224.9K | 313.4K |
| Gross profit | 1.7M | 2.3M |
| Gross profit margin, % | 88.5% | 88.0% |
| General and administrative expense | 801.5K | 806.0K |
| Operating expense total | 1.3M | 1.5M |
| Depreciation and amortization | 213.8K | 223.5K |
| EBIT | 436.8K | 335.7K |
| EBIT margin, % | 22.3% | 12.8% |
| Interest income | 30.5K | 1.4K |
| Interest expense | 130.6K | 81.4K |
| Pre tax profit | 336.7K | 254.6K |
| Income tax expense | 40.7K | 63.2K |
| Net Income | 296.0K | 191.3K |